No Cover Image

Journal article 69 views 23 downloads

Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model

Simone Pisano, Stefania Lenna, Gareth Healey Orcid Logo, Fereshteh Izardi, Lucille Meeks, Yajaira S. Jimenez, Oscar S Velazquez, Deya Gonzalez Orcid Logo, Steve Conlan Orcid Logo, Bruna Corradetti

Clinical and Translational Medicine, Volume: 11, Issue: 10

Swansea University Authors: Simone Pisano, Gareth Healey Orcid Logo, Deya Gonzalez Orcid Logo, Steve Conlan Orcid Logo, Bruna Corradetti

  • 58302.pdf

    PDF | Version of Record

    © 2021 The Authors. This is an open access article under the terms of the Creative Commons Attribution License.

    Download (18.67MB)

Check full text

DOI (Published version): 10.1002/ctm2.551

Abstract

BackgroundOvarian cancer (OC) is typically diagnosed late, associated with high rates of metastasis and the onset of ascites during late stage disease. Understanding the tumor microenvironment and how it impacts the efficacy of current treatments, including immunotherapies, needs effective in vivo m...

Full description

Published in: Clinical and Translational Medicine
ISSN: 2001-1326 2001-1326
Published: Wiley 2021
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa58302
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: BackgroundOvarian cancer (OC) is typically diagnosed late, associated with high rates of metastasis and the onset of ascites during late stage disease. Understanding the tumor microenvironment and how it impacts the efficacy of current treatments, including immunotherapies, needs effective in vivo models that are fully characterized. In particular, understanding the role of immune cells within the tumor and ascitic fluid could provide important insights into why OC fails to respond to immunotherapies. In this work, we comprehensively described the immune cell infiltrates in tumor nodules and the ascitic fluid within an optimized preclinical model of advanced ovarian cancer.MethodsGreen Fluorescent Protein (GFP)-ID8 OC cells were injected intraperitoneally into C57BL/6 mice and the development of advanced stage OC monitored. Nine weeks after tumor injection, mice were sacrificed and tumor nodules analyzed to identify specific immune infiltrates by immunohistochemistry. Ascites, developed in tumor bearing mice over a 10-week period, was characterized by mass cytometry (CyTOF) to qualitatively and quantitatively assess the distribution of the immune cell subsets, and their relationship to ascites from ovarian cancer patients.ResultsTumor nodules in the peritoneal cavity proved to be enriched in T cells, antigen presenting cells and macrophages, demonstrating an active immune environment and cell-mediated immunity. Assessment of the immune landscape in the ascites showed the predominance of CD8+, CD4+, B–, and memory T cells, among others, and the coexistance of different immune cell types within the same tumor microenvironment.ConclusionsWe performed, for the first time, a multiparametric analysis of the ascitic fluid and specifically identify immune cell populations in the peritoneal cavity of mice with advanced OC. Data obtained highlights the impact of CytOF as a diagnostic tool for this malignancy, with the opportunity to concomitantly identify novel targets, and define personalized therapeutic options.
Keywords: ascites; CyTOF; immunotherapy; mass cytometry; model; ovarian cancer; peritoneal cancers
College: Swansea University Medical School
Funders: European Union’s Horizon 2020 Research and Innovation Program, Grant/Award Number: 663830
Issue: 10